Authors: Holloway, R Shoulson, I Fahn, S Kieburtz, K Lang, A Marek, K McDermott, M Seibyl, J Weiner, W Welsh, M Kamp, C Day, D Pahwa, R Smith, D McGuire, D Barclay, L Sutherland, L Hildebrand, K Hubble, J Weeks, C LeWitt, P Mistura, K Bloomfield, W Miyasaki, J Duff, J Sime, E Suchowersky, O Argatoff, P Andreas, Y Kurth, M Brewer, M Russell, D Fussell, B Ford, B Dillon, S Hammerstad, J Stone, C Riley, D Rainey, P Standaert, D Tennis, M Wooten, F Rost-Ruffner, E Factor, S Brown, D Jankovic, J Beach, J Kurlan, R Gardiner, I Panisset, M Amyot, D Hall, J Rajout, A Wilson, W McCullan, L Brown, K Clark, R Rodnitzky, R Dobson, J Shults, C Fontaine, D Waters, C Welsh, M Pfeiffer, R Rast, S Bujak, G Casaceli, C Freimuth, A Hodgeman, K Honsinger, K Watts, A Hall, WJ Leventhal, CM Reich, S Tariot, P Balgoyen, D Corak, D Corrigan, M Driver, M Fraser, TJ Lai, PY Gomez-Mancilla, B Munting, J Peters, G Rowland, C Sullivan, H Trasky, R Wright, G Berber, E Morris, J Mills, D Hallak, L Rines, S

Citation: R. Holloway et al., A randomized controlled trial comparing pramipexole with levodopa in earlyParkinson's disease: Design and methods of the CALM-PD study, CLIN NEUROP, 23(1), 2000, pp. 34-44

Authors: Holloway, R Shoulson, I Kieburtz, K McDermott, M Tariot, P Kamp, C Day, D Shinaman, A Fahn, S Lang, A Marek, K Seibyl, J Weiner, W Welsh, M Pahwa, R Coe, S Barclay, L Sutherland, L Hildebrand, K Hubble, J Weeks, C LeWitt, P Miyasaki, J Duff, J Sime, E Suchowersky, O Stacy, M Kurth, M Brewer, M Harrigan, M Russell, DS Fussell, B Ford, B Dillon, S Hammerstad, J Stone, C Riley, D Rainey, P Standaert, D Tennis, M Wooten, F Rost-Ruffner, E Factor, S Brown, D Jankovic, J Atassi, F Kurlan, R Gardiner, I Panisset, M Amyot, D Hall, J Rajput, A Shirley, T Rodnitzky, R Dobson, J Shults, C Fontaine, D Waters, C Welsh, M Schuman, S Pfeiffer, R Rast, S Pfeiffer, B Brocht, A Casaceli, C Daigneault, S Hodgeman, K Honsinger, K O'Connell, C Watts, A

Citation: R. Holloway et al., Pramipexole vs levodopa as initial treatment for Parkinson disease - A randomized controlled trial, J AM MED A, 284(15), 2000, pp. 1931-1938

Authors: Shoulson, I Greenamyre, T Kieburtz, K Schwid, S McDermott, M Kayson, E Chase, T Fahn, S Lang, A Penney, J Hauser, R Gauger, L Kumar, R Keable, L Sime, E Siemers, E Belden, J Pappert, EJ Janko, K Trugman, JM Rost-Ruffner, E Kurlan, R Pearson, N Carter, J Nutt, J Stone, C Perlmutter, JS McGee-Minnich, L Freeman, A Duddleston, C Stacy, M Brewer, M Locke, B Stern, M Matthews, M Friedman, J Davies, R Lannon, M Grimes, D Gray, P Shults, C Fontaine, D O'Brien, C Dingmann, C Feigin, A Mazurkiewicz, J Elmer, L Wernette, K Singer, C Bateman-Rodriguez, D Carrion, A Fernandez, M Pfeiffer, R Pfeiffer, B Rast, S Pahwa, R McGuire, D Brin, M Walker, R Casaceli, C Day, D Hodgeman, K Huang, P Orme, C Sulimowicz, K Watts, A Means, E Alderfer, V Letizia, J Craun, AM Cooper, J Holdich, T Read, B

Citation: I. Shoulson et al., A multicenter randomized controlled trial of remacemide hydrochloride as monotherapy for PD, NEUROLOGY, 54(8), 2000, pp. 1583-1588

Authors: Shults, C Ray, J Tsuboi, K Gage, FH

Citation: C. Shults et al., Fibroblast growth factor-2-producing fibroblasts protect the nigrostriataldopaminergic system from 6-hydroxydopamine, BRAIN RES, 883(2), 2000, pp. 192-204

Authors: Brown, GG Rahill, AA Gorell, JM McDonald, C Brown, SJ Sillanpaa, M Shults, C

Citation: Gg. Brown et al., Validity of the dementia rating scale in assessing cognitive function in Parkinson's disease, J GER PSY N, 12(4), 1999, pp. 180-188

Authors: Roman, MJ Delis, DC Filoteo, JV Demadura, TL Paulsen, J Swerdlow, NR Swenson, MR Salmon, D Butters, N Shults, C

Citation: Mj. Roman et al., Is there a "subcortical" profile of attentional dysfunction? A comparison of patients with Huntington's and Parkinson's diseases on a global-local focused attention task", J CL EXP N, 20(6), 1998, pp. 873-884